|
Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
|
6 Months Ended |
9 Months Ended |
18 Months Ended |
|
Sep. 30, 2011
|
Sep. 30, 2012
|
Sep. 30, 2012
|
| Cash flows from operating activities: |
|
|
|
| Net loss |
$ (1,184) |
$ (9,318) |
$ (11,942) |
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: |
|
|
|
| Depreciation and amortization |
|
51 |
51 |
| Stock-based compensation expense |
40 |
859 |
1,205 |
| Changes in operating assets and liabilities: |
|
|
|
| Prepaid expenses and other current assets |
(2) |
(416) |
(460) |
| Accounts payable |
181 |
793 |
1,069 |
| Accrued expenses and other non-current liabilities |
455 |
359 |
845 |
| Net cash used in operating activities |
(510) |
(7,672) |
(9,232) |
| Cash flows from investing activities: |
|
|
|
| Purchases of property, plant, and equipment |
|
(704) |
(704) |
| Increase in restricted cash |
|
(93) |
(93) |
| Net cash used in investing activities |
|
(797) |
(797) |
| Cash flows from financing activities: |
|
|
|
| Proceeds from issuance of preferred stock, net of issuance costs |
6,099 |
34,992 |
41,091 |
| Net proceeds from issuance of common stock |
2 |
4,055 |
4,057 |
| Net cash provided by financing activities |
6,101 |
39,047 |
45,148 |
| Increase in cash and cash equivalents |
5,591 |
30,578 |
35,119 |
| Cash and cash equivalents at beginning of period |
|
4,541 |
|
| Cash and cash equivalents at end of period |
5,591 |
35,119 |
35,119 |
| Supplemental disclosure of non-cash financing activity |
|
|
|
| Accretion of convertible preferred stock to redemption value |
$ (101) |
|
$ (101) |